Zoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn't Change Thesis
May 17, 2018 1:06 PM EDTBMO Capital raised its price target on Zoetis Inc. (NYSE: ZTS) to $82.00 (from $80.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "We have updated our model to include Abaxis acquisition. Overall, we see a strong strategic rationale for the... More
Abaxis (ABAX) to Resume Trading at 7:30 am ET
May 16, 2018 7:03 AM EDTAbaxis (NASDAQ: ABAX) to Resume Trading at 7:30 am ET
... More